These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1277711)

  • 1. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):552-8. PubMed ID: 1277711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of coumarin anticoagulants XV: relationship between pharmacokinetics of dicumarol and warfarin in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1995-98. PubMed ID: 54415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.
    Yacobi A; Lampman T; Levy G
    Clin Pharmacol Ther; 1977 Mar; 21(3):283-6. PubMed ID: 837646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced elimination of warfarin during treatment with cholestyramine.
    Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
    Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
    Slattery JT; Levy G; Jain A; McMahon FG
    Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of coumarin anticoagulants XXIX: Elimination kinetics and anticoagulant activity of (S)-(-)-warfarin in rats before and after chronic administration.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1275-7. PubMed ID: 903865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrasubject variation of warfarin binding to protein in serum of patients with cardiovascular disease.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 Sep; 20(3):300-3. PubMed ID: 954352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients.
    Mellen CK; Ford M; Rindone JP
    Br J Clin Pharmacol; 2010 Jul; 70(1):139-42. PubMed ID: 20642557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.
    Holford NH
    Clin Pharmacokinet; 1986; 11(6):483-504. PubMed ID: 3542339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
    Jain A; McMahon FG; Slattery JT; Levy G
    Clin Pharmacol Ther; 1979 Jan; 25(1):61-6. PubMed ID: 758244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.
    Almog S; Shafran N; Halkin H; Weiss P; Farfel Z; Martinowitz U; Bank H
    Eur J Clin Pharmacol; 1985; 28(3):257-61. PubMed ID: 4007030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Warfarin Anticoagulant Reaction in Patients with Repeated Oral Tolvaptan Administration.
    Saito M; Ajioka M; Iwao T; Suzuki T
    Biol Pharm Bull; 2018 Jul; 41(7):1014-1016. PubMed ID: 29760305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
    Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats.
    Ogiso T; Iwaki M; Konishi Y
    J Pharmacobiodyn; 1982 Oct; 5(10):829-40. PubMed ID: 7161710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.
    Yacobi A; Wingard LB; Levy G
    J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of coumarin anticoagulants XXX: Relationship between total clearance and serum protein binding of dicumarol in rats.
    Lai CM; Levy G
    J Pharm Sci; 1977 Dec; 66(12):1739-41. PubMed ID: 72818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarin.
    Ermer JC; Hicks DR; Wheeler SC; Kraml M; Jusko WJ
    Clin Pharmacol Ther; 1994 Mar; 55(3):305-16. PubMed ID: 8143396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.